Genetically-modified Autologous T Cells drugs

2 medications in the FDA established pharmacologic class “Genetically-modified Autologous T Cells”.

DrugTypeNDC products
Kymriah
Tisagenlecleucel		Rx2
Yescarta
Axicabtagene ciloleucel		Rx1